24 CHAPTER 1 References 1. SIMPATHY-consortium. Polypharmacy Management by 2030: a patient safety challenge 2017. https://ec.europa.eu/chafea/health/newsroom/news/documents/polypharmacyhandbook-second-edition_en.pdf (accessed May 30, 2022). 2. World Health Organization. WHO global patient safety challenge: medication without harm. 2017. 3. World Health Organization. World Health Organization Technical Report; Medication Safety in Polypharmacy. 2019. 4. Leendertse AJ, Egberts ACG, Stoker LJ, Van Den Bemt PMLA. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008;168:1890–6. https://doi.org/10.1001/archinternmed.2008.3. 5. European Healthcare Connected Alliance. Medicines Optimisation Working Group 2022. https://echalliance.com/medicines-optimisation-working-group-about/ (accessed February 3, 2022). 6. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47(3):533-43. https://doi.org/10.1093/ajhp/47.3.533. 7. Billstein-Leber M, Carrillo CJD, Cassano AT, Moline K, Robertson JJ. ASHP guidelines on preventing medication errors in hospitals. Am J Heal Pharm 2018;1;75(19):1493-1517. https://doi.org/10.2146/ajhp170811. 8. Abbasi K. First do no harm: The impossible oath. BMJ 2019;366:4734. https://doi. org/10.1136/bmj.l4734. 9. Smith CM. Origin and uses of primum non nocere-above all, do no harm! J Clin Pharmacol 2005;45:371–7. https://doi.org/10.1177/0091270004273680. 10. Askitopoulou H, Vgontzas AN. The relevance of the Hippocratic Oath to the ethical and moral values of contemporary medicine. Part II: interpretation of the Hippocratic Oath—today’s perspective. Eur Spine J 2018;27:1491–500. https://doi.org/10.1007/ s00586-018-5615-z. 11. IOM. Institute of Medicine. To Err Is Human: Building a Safer Health System. To Err Is Hum. Build. a Safer Heal. Syst. 1999. 12. van der Hooft CS, Dieleman JP, Siemes C, Aarnoudse AJLHJ, Verhamme KMC, Strieker BHCH, et al. Adverse drug reaction-related hospitalisations: A population-based cohort study. Pharmacoepidemiol Drug Saf 2008;17(4):365–71. https://doi.org/10.1002/ pds.1565. 13. Eurostat. Ageing Europe - Looking at the lives of older people in the EU. Eurostat 2020:184. https://ec.europa.eu/eurostat/web/products-interactive-publications/-/ks08-21-259 (accessed February 3, 2022). 14. Mathers CD, Stevens GA, Boerma T, White RA, Tobias MI. Causes of international increases in older age life expectancy. Lancet 2015;385:540–8. https://doi.org/10.1016/ S0140-6736(14)60569-9. 15. MacKenbach JP, Slobbe L, Looman CWN, Van Der Heide A, Polder J, Garssen J. Sharp upturn of life expectancy in the Netherlands: Effect of more health care for the elderly? Eur J Epidemiol 2011;26:903–14. https://doi.org/10.1007/s10654-011-9633-y. 16. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet 2012;380:37–43. https://doi.org/10.1016/S01406736(12)60240-2.
RkJQdWJsaXNoZXIy MTk4NDMw